Analytics–Powered Approach To Patient Recruitment Strategy Enhances Endpoint Data Quality In Psychiatry Trial

In a significant Phase 3 psychiatry trial, a pharmaceutical company collaborated with Signant to transform patient recruitment. They moved beyond traditional methods by using PureSignal Analytics for data-driven site selection.

Instead of just focusing on recruitment speed and capacity, this innovative approach used real-time analytics to identify and prioritize sites with the highest quality clinician ratings. This was applied across more than 45 sites in two countries. The results were remarkable: the trial achieved enhanced endpoint data quality, optimized signal detection potential, and successful completion with over 500 patients strategically enrolled at top-performing sites.

This approach not only validated the use of analytics-powered recruitment strategies in psychiatry but also demonstrated that data quality can be prioritized without sacrificing enrollment efficiency.

Discover how Signant's PureSignal Analytics solution enabled systematic site performance evaluation, implemented gated recruitment processes, and fundamentally transformed traditional recruitment to deliver superior endpoint reliability.